B7H3 increases ferroptosis resistance by inhibiting cholesterol metabolism in colorectal cancer
Haiyan Jin,Mengxin Zhu,Dongze Zhang,Xiaoshan Liu,Yuesheng Guo,Lu Xia,Yanjun Chen,Yuqi Chen,Ruyan Xu,Cuiping Liu,Qinhua Xi,Suhua Xia,Tongguo Shi,Guangbo Zhang
DOI: https://doi.org/10.1111/cas.15944
IF: 5.7
2023-09-05
Cancer Science
Abstract:We reveal the regulatory role and mechanism of B7H3 in inhibiting ferroptosis in colorectal cancer (CRC) cells. Depletion of B7H3 in CRC cells promotes ferroptosis through AKT/sterol regulatory element binding protein 2 pathway‐mediated cholesterol metabolism. Ferroptosis, a newly discovered form of regulated cell death, has been reported to be associated with multiple cancers, including colorectal cancer (CRC). However, the underlying molecular mechanism is still unclear. In this study, we identified B7H3 as a potential regulator of ferroptosis resistance in CRC. B7H3 knockdown decreased but B7H3 overexpression increased the ferroptosis resistance of CRC cells, as evidenced by the expression of ferroptosis‐associated genes (PTGS2, FTL, FTH, and GPX4) and the levels of important indicators of ferroptosis (malondialdehyde, iron load). Moreover, B7H3 promoted ferroptosis resistance by regulating sterol regulatory element binding protein 2 (SREBP2)‐mediated cholesterol metabolism. Both exogenous cholesterol supplementation and treatment with the SREBP2 inhibitor betulin reversed the effect of B7H3 on ferroptosis in CRC cells. Furthermore, we verified that B7H3 downregulated SREBP2 expression by activating the AKT pathway. Additionally, multiplex immunohistochemistry was carried out to show the expression of B7H3, prostaglandin‐endoperoxide synthase 2, and SREBP2 in CRC tumor tissues, which was associated with the prognosis of patients with CRC. In summary, our findings reveal a role for B7H3 in regulating ferroptosis by controlling cholesterol metabolism in CRC.
oncology